Today: November 21, 2017, 2:09 am
  
Health

New Market Research Report: Interstitial Cystitis - Pipeline Review, H1 2017

New Drug Pipeline research report from Global Markets Direct is now available from Fast Market Research
New Market Research Report: Interstitial Cystitis - Pipeline Review, H1 2017
PR-Inside.com: 2017-05-19 17:09:41
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis - Pipeline Review, H1 2017, provides an overview of the Interstitial Cystitis (Genito Urinary System And Sex Hormones) pipeline landscape.

Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort to severe pain. Symptoms include decreased bladder capacity, painful sexual intercourse, chronic pelvic pain and a persistent, urgent need to urinate. Risk factors include age, gender and chronic pain disorder, such as irritable bowel syndrome or fibromyalgia. Treatment includes non-steroidal anti-inflammatory drug, antidepressants and antihistamines.


Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Interstitial Cystitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Interstitial Cystitis (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Full Report Details at
- www.fastmr.com/prod/1279388_interstitial_cystitis.aspx?afid=701

The Interstitial Cystitis (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 6, 1, 6 and 1 respectively.

Interstitial Cystitis (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Report Scope

* The pipeline guide provides a snapshot of the global therapeutic landscape of Interstitial Cystitis (Genito Urinary System And Sex Hormones).
* The pipeline guide reviews pipeline therapeutics for Interstitial Cystitis (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
* The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
* The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
* The pipeline guide reviews key companies involved in Interstitial Cystitis (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.
* The pipeline guide evaluates Interstitial Cystitis (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
* The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
* The pipeline guide reviews latest news related to pipeline therapeutics for Interstitial Cystitis (Genito Urinary System And Sex Hormones)

Reasons to Get this Report

* Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
* Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
* Find and recognize significant and varied types of therapeutics under development for Interstitial Cystitis (Genito Urinary System And Sex Hormones).
* Classify potential new clients or partners in the target demographic.
* Develop tactical initiatives by understanding the focus areas of leading companies.

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033&afid=701

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

Press Information


Published by
Bill Thompson
18008448156
e-mail
www.fastmr.com



# 789 Words
Related Articles
More From The Author
Global Humidifiers Market 2017-2021 - New Study [..]
A humidifier is a device that helps to regulate the humidity level in enclosed spaces and add moisture to the [..]
Report Published: "BRIC Aesthetic Lasers and Energy [..]
GlobalData's new report, "BRIC Aesthetic Lasers and Energy Devices Market Outlook to 2023", provides key market data [..]
Report Published: "Global Orthopedic Bracing and [..]
Orthopedic braces and support systems are used to restrict or assist physical movement, reduce weight-bearing forces, assist in [..]
Market Report, "Smokeless Tobacco in South Africa, [..]
Smokeless Tobacco in South Africa, 2017, is an analytical report by GlobalData that provides extensive and highly detailed current [..]
Switzerland Pharmaceuticals & Healthcare Report Q2 2017 [..]
Switzerland has a well-developed healthcare system and pharmaceutical industry with its citizens enjoying extensive access to [..]
 
More From Health
World Diabetes Day: Combating diabetic retinopathy in [..]
News release Preventing the preventable: Combating diabetic retinopathy in at risk women November 14, 2017 - report from Los [..]
Singapore eDevelopment's Biomedical Subsidiary Confirms 100% [..]
SINGAPORE, Nov 1, 2017 - (ACN Newswire) - Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today [..]
Endovision’s Range of Portable LED Examination Lights [..]
Endovision Australia, a leader in providing surgical instruments, has a range of portable LED examination lights that are excellent [..]
SGX-Listed Singapore eDevelopment Subsidiary Global BioLife [..]
SINGAPORE, Oct 24, 2017 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that U.S. [..]
Is Your Drinking Out of Control? Riverside [..]
Independent not-for-profit DrinkWise Australia has recently reported that Australians are drinking less and the rates of underage [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.